Alexandre Selmani
Overview
Explore the profile of Alexandre Selmani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Robertson C, Jacqmein J, Selmani A, Galarza K, Oster P
Hum Vaccin Immunother
. 2024 Nov;
20(1):2426868.
PMID: 39555800
Stage I of this study (NCT04142242) demonstrated the safety and immunogenicity of a booster dose of a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) and immune persistence 3 and 6-7 ...
2.
Hsiao A, Yee A, Izikson R, Fireman B, Hansen J, Lewis N, et al.
AJOG Glob Rep
. 2024 Nov;
4(4):100395.
PMID: 39512761
Background: The Advisory Committee on Immunization Practices (ACIP) and the American College of Obstetricians and Gynecologists (ACOG) recommend that all pregnant persons receive any licensed, recommended, and age-appropriate inactivated influenza...
3.
Robertson C, Jacqmein J, Selmani A, Galarza K, Oster P
Hum Vaccin Immunother
. 2023 Jan;
19(1):2160600.
PMID: 36632042
This 2-stage Phase III study (NCT04142242) of a recently licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) assessed the safety and immunogenicity of a booster dose in older adults (≥59 years)...
4.
Robertson C, Mercer M, Selmani A, Klein N, Jeanfreau R, Greenberg D
Pediatr Infect Dis J
. 2018 Nov;
38(3):323-328.
PMID: 30395011
Background: For children <3 years of age, a half dose of inactivated influenza vaccine (7.5 μg hemagglutinin per strain) has been used for more than 30 years, but several studies...